| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000013107 |
| Receipt No. | R000015289 |
| Official scientific title of the study | Examination of the effect that EMLA cream gives for a rocronium dosage time ache. |
| Date of disclosure of the study information | 2014/02/07 |
| Last modified on | 2017/08/11 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Examination of the effect that EMLA cream gives for a rocronium dosage time ache. | |
| Title of the study (Brief title) | Examination of the effect that EMLA cream gives for a rocronium dosage time ache. | |
| Region |
|
|
| Condition | ||
| Condition | The patient who has an operation under anesthesia in our hospital. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | When I perform tracheal intubation, the dosage of the muscle relaxant is necessary for general anesthesia. Action time of onset is early as muscle relaxant, and rocuronium which duration of action has a short is generally used now. It is said that rocuronium has a strong pain in the dosage and may be accompanied by body movement in the dosage. I am in danger of an intravenous feeding false withdrawal, a gastric content countercurrent, the aspiration by body movement. Various methods (opioid, the intravenous precedent dosage of the local anesthetic) are performed as a method to reduce a rocuronium dosage time ache. However, a circulation change may become unstable by the precedent drug dosage, and it is difficult to give the precedent dosage for all cases. The EMLA cream which was lidocaine propitocaine combination cream was released in Japan in 2013. This drug has adaptation for painkilling with the laser treatment. It is intended to consider whether you can reduce a rocuronium dosage time ache by applying EMLA cream to skin. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | We evaluate it by sharp pain score, a vital change after the rocuronium dosage. |
| Key secondary outcomes | |
| Base | |
| Study type | |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Control group: application posterior vein secures a basis from the back of hand to the forearm. | |
| Interventions/Control_2 | Emura group: application posterior vein from the EMLA cream back of hand to the forearm 45 minutes before venepuncture | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Planned operation patient under the general anesthesia | |||
| Key exclusion criteria | The patient who uses a local anesthetic before general anesthesia. | |||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Daisuke Sugiyama |
| Organization | Shinshu University |
| Division name | Department of Anesthesiology and Resuscitology |
| Address | 3-1-1 Asahi, Matsumoto, Nagano |
| TEL | 0263-37-2670 |
| sugidai@shinshu-u.ac.jp | |
| Public contact | |
| Name of contact person | Daisuke Sugiyama |
| Organization | Shinshu University |
| Division name | Department of Anesthesiology and Resuscitology |
| Address | 3-1-1 Asahi, Matsumoto, Nagano |
| TEL | 0263-37-2670 |
| Homepage URL | |
| sugidai@shinshu-u.ac.jp | |
| Sponsor | |
| Institute | Shinshu University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Anesthesiology and Resuscitology, Shinshu University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015289 |